Pacira BioSciences
PCRX
PCRX
180 hedge funds and large institutions have $1.64B invested in Pacira BioSciences in 2017 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 82 increasing their positions, 43 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
180
Holders Change
-16
Holders Change %
-8.16%
% of All Funds
4.49%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
27
Increased
82
Reduced
43
Closed
41
Calls
$46.7M
Puts
$16.2M
Net Calls
+$30.5M
Net Calls Change
+$25.9M
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
$51.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$40.7M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
$49.2M |
| 4 |
HM
HealthCor Management
New York
|
$96.8M |
| 5 |
PC
PointState Capital
New York
|
$42.7M |
